We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CHRO market cap is 11.59M. The company's latest EPS is USD -1.2798 and P/E is -1.57.
| Quarter End | ||
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Revenue | ||
| Operating Income | ||
| Net Income |
| Year End 31 December 2023 | 2022 | 2023 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 |
| Operating Income | -2.32M | -6.86M |
| Net Income | -2.46M | -7.38M |
| Quarter End | ||
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Assets | ||
| Total Liabilities | ||
| Total Equity |
| Year End 31 December 2023 | 2022 | 2023 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Assets | 55k | 96k |
| Total Liabilities | 3.76M | 6.54M |
| Total Equity | -3.71M | -6.45M |
| Market Cap | 11.59M |
| Price to Earnings Ratio | -1.57 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 121.08 |
| Price to Book Ratio | -1.8 |
| Dividend Yield | - |
| Shares Outstanding | 5.77M |
| Average Volume (1 week) | 33.57k |
| Average Volume (1 Month) | 23.35k |
| 52 Week Change | -66.50% |
| 52 Week High | 6.00 |
| 52 Week Low | 1.21 |
| Spread (Intraday) | 0.76 (27.44%) |
| Company Name | Chromocell Therapeutics Corporation |
| Address |
108 west 13th st wilmington, delaware 19801 |
| Website | https://chromocell.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
